Hello,



  • This field is for validation purposes and should be left unchanged.
EECO2 Privacy Policy

Latest News

EECO2's Life Sciences Saver

EECO2 LAUNCHES LIFE SCIENCES SAVER

Posted on

DATA-DRIVEN INSIGHTS TO REDUCE SITE ENERGY, CARBON AND COST

20th May 2021 – Press Release

EECO2 is proud to announce the introduction of their Life Sciences Saver, a new resource now available on the EECO2 website. EECO2’s data-driven tool allows strategic teams, energy managers, engineering directors, HSE managers, and procurement professionals to estimate a site’s potential energy, carbon and cost reduction opportunities through energy efficiency projects in the life sciences and high-tech industries.

The tool will use a site’s energy consumption data alongside industry-leading data from projects EECO2 has undertaken to provide quantitative, evidence-based savings potential. Results will provide visibility into the energy, carbon, and cost reduction opportunities available and can be used to communicate reduction targets and be a starting point on a journey to achieving sustainability goals

The Life Sciences Saver was created with a holistic view of carbon, cost, and compliance in mind. The integrated approach acknowledges that energy alone is not enough. Risk-based analysis and careful evaluation of quality aspects provide opportunities to improve compliance while reducing energy, carbon, and cost. This is especially important due to the savings identified by the algorithm being primarily related to HVAC systems and cGMP areas. HVAC systems within regulated environments are typically responsible for consuming up to 40-80% of a site’s total energy, and therefore also tend to represent the largest opportunity for improvement.

Visit the Life Sciences Saver to gain an insight into the potential savings your life sciences site could make.

 

About EECO2

EECO2 is a leading global provider of researched, tested, and proven engineered efficient and cGMP compliant solutions for the life science and high-tech industries.

Project offerings vary in size and scope, notably including delivering improvements across existing sites, considering everything from renewable energy supply to switch off optimisation plans. Clients also commission them to incorporate energy-efficient design into new capital projects through simulation and modelling. This includes reviewing plans at various stages through the design process to assess them for energy and sustainability and challenging engineering design companies to make improvements.

EECO2 hold CIBSE certified status as Low Carbon Consultants (LCC) Building Design, Building Operation and Simulation, Low Carbon Energy Assessors and ESOS Lead Assessors, and we are also members of the Energy Institute and IMEA.

PREVIOUS POST

browse latest news

Latest tweets

As 50% of energy consumption in #lab equipment occurs when unoccupied, clarifying and understanding the largest energy users within a science-based environment is highly beneficial to cost reduction efforts and measures to reduce carbon output.

#sustainability #netzero

In just under 2 weeks, @EECO2_Energy will be joining the conversation at @ISPEorg leading the discussion on the challenges and opportunities the #pharma industry faces in achieving net zero carbon.

Find out more: https://ispe.org/conferences/2021-annual-meeting-expo/register

As we learned from our talk with @My_Green_Lab, reducing greenhouse gas emissions does not have to be a one-way street. Prioritising projects that deliver improved energy efficiency will ultimately offer the greatest payback.

See our bio for more!

#netzero #energy #pharma

Sign up to the knowledge hub

Latest News

LABORATORY SUSTAINABILITY AND INNOVATION

Posted on

The average laboratory uses 5 times as much energy as the average office building.* Sustainability can no longer afford to be seen as a trend, and the development of sustainable practices should be incorporated into many areas, including labs.
 
We recently attended Lab Innovations‘ Lab Live: Sustainability event, which highlighted leading sustainable practices, products, and initiatives within the laboratory industry. Thank you to Andy Evans of Green Light Laboratories, Martin Farley of UCL, and Harleen Chima & Robert Hunt of Kimberly-Clark for delivering their hugely valuable respective sessions.

There are many ways of improving sustainable practices within the industry – from using and maintaining lab equipment effectively, through to reducing water usage. Get in touch to find out how EECO2 can help you optimise your laboratory for energy efficiency.

View a recent case study where we reduced our client’s carbon emissions by 985 tonnes per year:

LABORATORY OPTIMISATION AND UPGRADES FOR ENERGY EFFICIENCY.


*Source: Lab Innovations

PREVIOUS POSTNEXT POST

browse latest news

Latest tweets

As 50% of energy consumption in #lab equipment occurs when unoccupied, clarifying and understanding the largest energy users within a science-based environment is highly beneficial to cost reduction efforts and measures to reduce carbon output.

#sustainability #netzero

In just under 2 weeks, @EECO2_Energy will be joining the conversation at @ISPEorg leading the discussion on the challenges and opportunities the #pharma industry faces in achieving net zero carbon.

Find out more: https://ispe.org/conferences/2021-annual-meeting-expo/register

As we learned from our talk with @My_Green_Lab, reducing greenhouse gas emissions does not have to be a one-way street. Prioritising projects that deliver improved energy efficiency will ultimately offer the greatest payback.

See our bio for more!

#netzero #energy #pharma

Sign up to the knowledge hub

Latest News

EECO2's Life Sciences Saver

COMING SOON: EECO2’S LIFE SCIENCES SAVER

Posted on

EECO2 is excited to announce our new FREE-to-use Life Sciences Saver COMING SOON!


Our aim is to provide visibility into the potential energy, carbon, and cost savings opportunities available in the life sciences industry to help achieve sustainability targets and goals.

The Life Sciences Saver has been developed using industry-leading data, collected from energy savings projects undertaken by EECO2 since 2017.

Considering that EECO2 identified savings of over 295,000 MWh, 21.3 million dollars, and 90,000 tonnes of CO2 for our clients last year alone, we are thrilled to be introducing our new service.

Keep an eye on our LinkedIn page and here on our website for more information!

See the results in action with EECO2’s case studies.

EECO2's client energy savings data

PREVIOUS POSTNEXT POST

browse latest news

Latest tweets

As 50% of energy consumption in #lab equipment occurs when unoccupied, clarifying and understanding the largest energy users within a science-based environment is highly beneficial to cost reduction efforts and measures to reduce carbon output.

#sustainability #netzero

In just under 2 weeks, @EECO2_Energy will be joining the conversation at @ISPEorg leading the discussion on the challenges and opportunities the #pharma industry faces in achieving net zero carbon.

Find out more: https://ispe.org/conferences/2021-annual-meeting-expo/register

As we learned from our talk with @My_Green_Lab, reducing greenhouse gas emissions does not have to be a one-way street. Prioritising projects that deliver improved energy efficiency will ultimately offer the greatest payback.

See our bio for more!

#netzero #energy #pharma

Sign up to the knowledge hub

Latest News

CLEANROOM COST, QUALITY & ENVIRONMENTAL SUSTAINABILITY: CAN YOU AFFORD TO COMPROMISE?

Posted on

EECO2’s Executive Director, Keith Beattie, recently presented on ‘Cleanroom Cost, Quality & Environmental Sustainability: Can You Afford to Compromise?’ at ISPE Boston‘s Virtual Spring Conference.

The presentation covered the many options open to cleanroom users to minimise the energy consumption and operational costs of these highly energy-intensive spaces. There are many efficiency improvements available that have proven to have no detrimental impact on the critical product quality needs. 

Topics discussed included:

  • Practical & proven top tips you can apply today to make a real & significant improvement
  • The business case to support action, illustrated with case studies
  • Future game-changing innovation in cleanroom controls

Feel free to contact us if you would like to know more about the presentation content or discuss any topics in more detail.

PREVIOUS POSTNEXT POST

browse latest news

Latest tweets

As 50% of energy consumption in #lab equipment occurs when unoccupied, clarifying and understanding the largest energy users within a science-based environment is highly beneficial to cost reduction efforts and measures to reduce carbon output.

#sustainability #netzero

In just under 2 weeks, @EECO2_Energy will be joining the conversation at @ISPEorg leading the discussion on the challenges and opportunities the #pharma industry faces in achieving net zero carbon.

Find out more: https://ispe.org/conferences/2021-annual-meeting-expo/register

As we learned from our talk with @My_Green_Lab, reducing greenhouse gas emissions does not have to be a one-way street. Prioritising projects that deliver improved energy efficiency will ultimately offer the greatest payback.

See our bio for more!

#netzero #energy #pharma

Sign up to the knowledge hub

Latest News

DELIVERING ENERGY EFFICIENCY, CARBON REDUCTION, AND IMPROVED COMPLIANCE TO LIFE SCIENCE SECTOR IN 2020.

Posted on

Our mission is to help improve global sustainability within the life science sector, with our innovation, integrity, and professionalism, to create a greener world for the next generation. 

I am delighted to be introducing EECO2’s inaugural MD statement, the first of many to come. 

In 2020, we continued our momentum from previous years through the continued support of global pharmaceutical companies to deliver their energy efficiency and carbon reduction strategies at the site, regional and global levels. 

It was an exciting and eventful year for many reasons; we continued delivering innovative energy efficiency projects which support our customers in carbon and cost reduction while also improving compliance. It also presented the opportunity to work more closely with our customers on new opportunities, solutions, and products. 

Last year was most notably affected by the impact of the COVID-19 virus, which has affected people across the world on an unprecedented scale. Although, as with all demanding situations, we must look at the positives that have emerged during this period – most notably the clear realization of the effect carbon and greenhouse gas emissions are having on our planet. 

On a global scale, it has provided the wake-up call and unity that is required by international communities, of how we can come together to alter the course of the world and change it for the better. Our clients across the life science industry are a prime example of this, coming together and collaborating to deliver multiple vaccines to enable people, countries, and the world to see the light at the end of the tunnel. 

Although it was an unusual year, we have committed and continued to provide tangible long-term value to our customers by assessing, defining, and delivering cost-effective energy solutions. Through collaboration and providing innovative services and products, we support our customers to achieve their sustainability and energy targets, focusing on their current priorities to how they may evolve in the future. 

I am extremely proud of all that our team, both existing and new, have achieved in 2020, and we truly saw what we are capable of throughout the year. The resilience showed in face of various challenges presented by the pandemic, and their ability to overcome and embrace new ways of working, has been nothing short of exceptional, and a testament to the values and environment we are building here at EECO2. 

Together, I am confident that we will continue to build on our success whilst continuing to be at the forefront of innovation and providing unrivaled services to help our customers across the life science industry and beyond to meet their energy and carbon targets on a global scale. Our solutions, experience, and expertise allow us to play a critical role in the development of sustainable pharmaceutical operations and supply chain, whilst improving quality and compliance. 

We are Moving Fast 

At the beginning of last year, EECO2 had recorded one of its most successful years to date, completing projects for several leading global pharmaceutical companies across numerous locations around the world. In 2020, we continued this growth, delivering projects remotelyusing our innovative, purpose-built systems where required, resulting in identified savings of over 295,000 MWh21.3 million dollars, and 90,000 tonnes of CO2 – the equivalent to 10,445 homes energy usage for one year. 

Last year we continued to grow our global footprint delivering projects at pharmaceutical manufacturing sites across North & South America, Europe, Africa & Asia. Even with the constraints caused by the pandemic, our ability to innovate and utilize technologies allowed us to deliver virtual site visits using tools such as Matterport and 3D Cameras. Although we are confident of being able to collaborate with our customers on-site in the not-to-distant future, remaining dynamic in our business processes is crucial to continue to support our customers in delivering lifesaving care and the COVID-19 vaccine. 

It is clear that the targets set by the global life science industry, around large reductions or even carbon negative footprints, are not achievable without efficiency. It is integral to assess and deliver projects that change or modify existing assets to perform optimally and only utilize the energy that is needed. Typically, around half of a site can be made more efficient, with 50% of that being economically viable to deliver. Our expertise in HVAC and GMP areas, where the vast number of energy-saving opportunities can be found, can considerably help to drive down efficiency whilst maintaining critical requirements.  

This has become even more of a requirement, with leading pharmaceutical companies such as AstraZenecaGSK and, Pfizer having a clear focus on building momentum for sustainability and carbon reduction by 2030. We are proud to have worked on developing an outline of the high-impact steps required at the global, regional and, site level to achieve the sustainability goals of several leading companies. This included major insight into what was needed to refine the operating model to deliver major progress on the procurement of renewable electricity and the general engagement and enthusiasm of teams (at global and site level).  

We also focused on developing organizational-level and site-level decarbonization roadmaps, undertaking a gap analysis to identify a range of additional solutions to deliver the targets, providing robust operational and capital financial assessments of delivering the ambition, as well as the potential technical challenges. Ultimately, this defined the operating model and governance structure required to set up for success and enable the delivery of the roadmap.  

We also began to focus on another critical area of sustainability by offering water assessments to understand and deliver projects to reduce water usage and waste. Last year alone we identified an average of 15 million m3 of water savings, with £170,000 of savings accounting for 30% of site usage. With energy, carbon and, water constituting three of the four main sustainability pillars, it is an integral addition to the services we provide our customers. 

Our R&D efforts also gained considerable momentum with our ground-breaking Intelligent Cleanroom Control System (ICCS) being installed in the first-of-its-kind Cleanroom in the UK that EECO2 has designed and is currently building. We are also developing pilots for ICCS retrofits to existing cleanrooms in the US which will allow our customers the opportunity of 60% energy reduction compared to static systems. We are excited to see the completed project validated and commissioned later this year, with more in the pipeline. 

Our delivery of design services has also increased, from concept through to detailed design for specific projects to new buildings and expansions. Although the change in building approach has changed in the last 10 years, traditionally we are maintaining a legacy thought process of always delivering what we have done before. We are focused on challenging the status quo and creating innovative designs that are energy efficient from inception to reduce the requirement of extensive modifications in the future. 

Each of these projects shows the potential of our business to directly influence the future of sustainability within life science globally and enable the success and growth of more pharmaceutical manufacturers across the world. With every assessment, design project, or product installation we complete, we’re evolving, refining, and improving our expertise and solutions. Each project and discussions add something new and drive our solutions and products forward. 


Priorities in 2021
 

At EECO2, we are focused on continual improvement, building on our successes, and delivering value to our customers.  

This year we will continue to build on our core strengths and utilize learned knowledge to add new capabilities, both internally and externally, to continue to add new dimensions to EECO2 – delivering both innovation and value to our customers to help… 

Four key areas that we are going to prioritize in 2021 are: 

Focusing on our Core — We will continue to drive collaboration and strategic change for both current and new customers across the life science industry. As our customers continue to innovate to deliver a better quality of life, we will continue to enable them to deliver on their strategic targets with our innovative services and solutions.  

Revisit our Value Proposition — With our customers continuing to challenge the limits of sustainable change in the life science industry, we must focus internally on what we can do to not only be a part of the solution but also deliver the solution. We will continue to ‘walk the walk’ by driving the decarbonization of our operations whilst working with our customers to deliver substantial change.  

Adding New Capabilities — Following last year’s precedent, we will continue to expand our services and solutions to provide value across our customers’ organizations and the wider life science industry. We are providing further support for improving not only energy but also water efficiency, improved metering, and visualization technology, as well as collaborative tools and workshops to share best practices to drive change across the entire organization. This also includes expanding the team here at EECO2 and challenging continual improvement across our operation. 

Continued Execution for Customers — The pandemic has shifted our way of working, both in the solutions we offer and delivery. We will continue to innovate to ensure our customers can maintain their focus on energy efficiency within the timelines they have set by offering improved remote site assessments and COVID-19 risk assessments of their facilities.  

The utilization of our workshops from strategic through to quality and compliance has also increased as we look to engage with key stakeholders across an organization to show what is possible to deliver – in a compliant, efficient way. With new products, solutions, and ways of working, we will continue to adapt to the ever-changing needs of our customers. 

The most important thing is that we continue to execute for customers and deliver the results we’re capable of. The outputs show precisely the kind of impact we can have for our customers across their organizations. Each company we work with sees significant cost, carbon, and energy savings which drive down business-as-usual operating costs in the future. It is that simple. We just need to keep delivering for customers.  


This Time Next Year
 

This time next year there will be more global alignment on sustainability and carbon reduction, not only within the life science sector but across all sectors, both public and private. 

The life science industry itself will be not only aligning but increasing the pace of change to hit the critical milestones that are required to hit their global targets. Therefore, as we have seen with the collaborations due to COVID, the ever-changing merger and acquisition landscape and updated science-based targets for 2021, the acceleration for most companies in this space is significant. 

Overall, it is evident that innovation is required because we are not going to get there as we are, however, business as usual must continue, so the focus on improving existing facilities and building new facilities, and instilling energy efficiency from the beginning is becoming more critical with each passing month. 

The policy landscape is also changing, maybe not so much in the next year, but in the next 10-15 years policies will change to reflect the monumental shift to achieve global carbon reduction targets by 2040, so expect taxation legislation to change, causing issues on companies relying on offsets. 

We are going to work closely with customers to collaborate and create features or solutions that support the more diverse needs of our customers. If we keep listening to their needs and challenges, the potential in our business is limitless. 

Part of this sharing our knowledge and expertise, whether that is on our platform or others, to discuss ideas, data, and results that we have seen across the industry. We want to evangelize energy efficiency and carbon reduction in pharmaceutical manufacturing and share our customers’ success stories.  

There has never been a more exciting time for our business and industry. I for one, am looking forward to a huge 2021 and helping to facilitate the shift to carbon-neutral (or negative) operations, one tonne of carbon at a time.


Rob Wallace BEng CEng FCIBSE LCC
Managing Director

EECO2 (Energy Efficiency Consultancy Limited)

www.eeco2.com

PREVIOUS POSTNEXT POST

browse latest news

Latest tweets

As 50% of energy consumption in #lab equipment occurs when unoccupied, clarifying and understanding the largest energy users within a science-based environment is highly beneficial to cost reduction efforts and measures to reduce carbon output.

#sustainability #netzero

In just under 2 weeks, @EECO2_Energy will be joining the conversation at @ISPEorg leading the discussion on the challenges and opportunities the #pharma industry faces in achieving net zero carbon.

Find out more: https://ispe.org/conferences/2021-annual-meeting-expo/register

As we learned from our talk with @My_Green_Lab, reducing greenhouse gas emissions does not have to be a one-way street. Prioritising projects that deliver improved energy efficiency will ultimately offer the greatest payback.

See our bio for more!

#netzero #energy #pharma

Sign up to the knowledge hub

Latest News

ALFRED LEUNG MEMORIAL AWARD: BRIDGING THE GAP BETWEEN INDUSTRY AND ACADEMIA

Posted on

At EECO2, our ethos is one of continuous improvement both within our team and for our clients. One of the newer members of our team, Tanju Beyoglu, demonstrates this ethos through his recent achievement – the Alfred Leung Memorial Award.


News Spotlight

The inaugural Alfred Leung Memorial Award has been presented to Tanju in recognition of his contribution to promoting the building services engineering community, with outstanding efforts attesting to bridging the gap between industry and academia.

Background

Tanju recently completed his MSc Building Services Engineering, graduating with distinction from Leeds Beckett University. At the end of 2020, he joined the EECO2 team as an Intermediate HVAC Engineer.

Alfred Leung Memorial Award

The award was inaugurated by CIBSE in honour of the late Dr Alfred Leung – the former regional chair who dedicated himself to ‘facilitating high achievement of students both past and present’. [1]

Tanju says “What made the award much more meaningful, [even] more than the hard work and effort spent during the studies, was the purpose of the prize: to commemorate such an inspirational individual who devoted his life to education and our community.”

Well done, Tanju!

[1] Paul Guyers, chairman of CIBSE Merseyside and North Wales Regional Committee


Read more recent news from EECO2.

PREVIOUS POSTNEXT POST

browse latest news

Latest tweets

As 50% of energy consumption in #lab equipment occurs when unoccupied, clarifying and understanding the largest energy users within a science-based environment is highly beneficial to cost reduction efforts and measures to reduce carbon output.

#sustainability #netzero

In just under 2 weeks, @EECO2_Energy will be joining the conversation at @ISPEorg leading the discussion on the challenges and opportunities the #pharma industry faces in achieving net zero carbon.

Find out more: https://ispe.org/conferences/2021-annual-meeting-expo/register

As we learned from our talk with @My_Green_Lab, reducing greenhouse gas emissions does not have to be a one-way street. Prioritising projects that deliver improved energy efficiency will ultimately offer the greatest payback.

See our bio for more!

#netzero #energy #pharma

Sign up to the knowledge hub

Latest News

CLEANROOM TECHNOLOGY CONFERENCE 2020

Posted on

EECO2 attended and presented at 2020’s virtual Cleanroom Technology Conference.

It was an insightful two days listening to cutting-edge guidance, news and latest industry innovations. EECO2’s Director Keith Beattie presented on the topic of ‘improving quality and compliance in cleanrooms, whilst reducing energy consumption, carbon emissions and cost’.

If you could not attend the 2-day event here are 5 key takeaways.

1. RUBBISH IN = RUBBISH OUT

Data integrity is essential to GMP and making informed decisions. If your data integrity is not already in place, then there is no point taking it any further, therefore a review of data collection tools is crucial for effectiveness.

2. TECHNOLOGY & AUTOMATION

Environmental sampling and monitoring are manual and notoriously prone to error due to the large number of data points, pieces of paper and excel spreadsheets. Technological innovations are now available to automate & optimise these processes to save both time & money.

3. CLEANROOM MONITORING IS KEY

Monitoring of different pressures, temperature and humidity is critical to reducing the risk of out-of-specification conditions, energy usage, carbon emissions and cost with closed loop control being recommend to drive and control output systems.

4. ISO STANDARDS WORTH KNOWING

ISO 14644-16 provides a framework and methodology to better understand how adjusting parameters such as differential pressure and air change rates can provide energy efficiency benefits without risk to quality operational cleanroom performance.

5. ENERGY EFFICIENCY

Up to 70% of cleanroom and pharma manufacturing energy consumption comes from HVAC. Simple changes to air filters, fans and pressure drops can have a significant impact on energy consumption reduction bringing your site and organisation closer to your Scope 1 & 2 targets.

After Keith Beatie’s presentation, there was a live Q&A session to answer any further questions, however, if you want to know more feel free to get in touch.

PREVIOUS POSTNEXT POST

browse latest news

Latest tweets

As 50% of energy consumption in #lab equipment occurs when unoccupied, clarifying and understanding the largest energy users within a science-based environment is highly beneficial to cost reduction efforts and measures to reduce carbon output.

#sustainability #netzero

In just under 2 weeks, @EECO2_Energy will be joining the conversation at @ISPEorg leading the discussion on the challenges and opportunities the #pharma industry faces in achieving net zero carbon.

Find out more: https://ispe.org/conferences/2021-annual-meeting-expo/register

As we learned from our talk with @My_Green_Lab, reducing greenhouse gas emissions does not have to be a one-way street. Prioritising projects that deliver improved energy efficiency will ultimately offer the greatest payback.

See our bio for more!

#netzero #energy #pharma

Sign up to the knowledge hub

Latest News

NEW CASE STUDY LOCATION – TURKEY

Posted on


It is always exciting adding another location onto the EECO2 case study map. It allows our clients to see where the team has traveled to, what kind of projects we have covered and in which locations. This time, the new case study is in Turkey.

The case study focuses on a detailed site survey on potential energy savings within the HVAC systems of a pharmaceutical manufacturer in Turkey. But when the EECO2 team fitted one of the larger HVAC systems with the MEMU, two additional potential energy saving projects were uncovered.

Results: £12,000 per year on 1 AHU!

READ THE CASE STUDY


If you want to see how our Case Study map looks now – click here.

For more information on the MEMU, get in touch today on info@eeco2.com.

Remember to follow our LinkedIn page!

PREVIOUS POSTNEXT POST

browse latest news

Latest tweets

As 50% of energy consumption in #lab equipment occurs when unoccupied, clarifying and understanding the largest energy users within a science-based environment is highly beneficial to cost reduction efforts and measures to reduce carbon output.

#sustainability #netzero

In just under 2 weeks, @EECO2_Energy will be joining the conversation at @ISPEorg leading the discussion on the challenges and opportunities the #pharma industry faces in achieving net zero carbon.

Find out more: https://ispe.org/conferences/2021-annual-meeting-expo/register

As we learned from our talk with @My_Green_Lab, reducing greenhouse gas emissions does not have to be a one-way street. Prioritising projects that deliver improved energy efficiency will ultimately offer the greatest payback.

See our bio for more!

#netzero #energy #pharma

Sign up to the knowledge hub

Latest News

ispe conf

ISPE UK ANNUAL CONFERENCE 2018

Posted on


This week, EECO2 is attending ISPE’s UK Annual Conference. EECO2 will be at stand 15, so if you are planning to attend, come and speak to the team. The theme for this year is: FUTURE PHARMA: Paradigm Shift or Business as Usual? 

ISPE introduces the idea below;
‘“Paradigm Shift” has possibly been an overused phrase in recent years when considering how Pharmaceutical Manufacturing will develop in the future.  It suggests a fundamental or even a radical change in our industry, a revolution is upon us perhaps but are we really seeing this happen?

The ISPE UK Annual Conference aims to challenge this notion, in what is a conservative, somewhat risk-averse and highly regulated industry where efficacy and patient safety must always be in the forefront of any decision making process.’

Attending an event like this is great to make new connections with people in the industry, as well as improve and develop relationships with people you already know. The team is looking forward to showcasing the EECO2 services, listening to some interesting talks and making new connections.

ispe

If you take a look at the agenda, it looks like it will be a great event!

“Join the UK Annual Conference to hear from Industry and Regulators as we move to a post Brexit environment and hear both sides of the story.”

To learn more about what the team have been working on, take a look at our new Case Studies.

PREVIOUS POSTNEXT POST

browse latest news

Latest tweets

As 50% of energy consumption in #lab equipment occurs when unoccupied, clarifying and understanding the largest energy users within a science-based environment is highly beneficial to cost reduction efforts and measures to reduce carbon output.

#sustainability #netzero

In just under 2 weeks, @EECO2_Energy will be joining the conversation at @ISPEorg leading the discussion on the challenges and opportunities the #pharma industry faces in achieving net zero carbon.

Find out more: https://ispe.org/conferences/2021-annual-meeting-expo/register

As we learned from our talk with @My_Green_Lab, reducing greenhouse gas emissions does not have to be a one-way street. Prioritising projects that deliver improved energy efficiency will ultimately offer the greatest payback.

See our bio for more!

#netzero #energy #pharma

Sign up to the knowledge hub

Latest News

hybrid

EECO2’S NEW HYBRID ADDITION

Posted on

EECO2 welcomes a new addition to the company fleet. This Toyota C-HR brings the total of hybrid vehicles within EECO2 up to 4. The Toyota C-HR delivers lower emission levels than traditional engine cars, with a combined CO2 emission of 86 g/km.

By using both a conventional engine and electric motor, hybrids achieve significantly better fuel efficiency than their non-hybrid counterparts. They also pollute less and save drivers money through fuel savings. As EECO2 is an energy efficiency specialist, working with our clients each day to lower energy consumption and carbon emissions, it makes sense that we, as a team, do our part too and lead by example.

“With low fuel-consumption comes low emissions; our Hybrid cars boast some of the lowest CO2 emissions in their classes and very low levels of harmful nitrogen oxides (NOx)” Toyota, UK.

Benefits of Hybrid cars:

  • Cleaner energy
  • Incentives
  • Regenerative braking
  • Reduced fuel dependence
  • Weight savings
  • Smaller engines
  • Higher resale value

We aim to continue to find ways within EECO2 to reduce our carbon footprint and encourage others to do the same.

 

PREVIOUS POSTNEXT POST

browse latest news

Latest tweets

As 50% of energy consumption in #lab equipment occurs when unoccupied, clarifying and understanding the largest energy users within a science-based environment is highly beneficial to cost reduction efforts and measures to reduce carbon output.

#sustainability #netzero

In just under 2 weeks, @EECO2_Energy will be joining the conversation at @ISPEorg leading the discussion on the challenges and opportunities the #pharma industry faces in achieving net zero carbon.

Find out more: https://ispe.org/conferences/2021-annual-meeting-expo/register

As we learned from our talk with @My_Green_Lab, reducing greenhouse gas emissions does not have to be a one-way street. Prioritising projects that deliver improved energy efficiency will ultimately offer the greatest payback.

See our bio for more!

#netzero #energy #pharma

Sign up to the knowledge hub